Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2007-05-08 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 10-Q 50 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-O' and is described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2007.' It contains detailed financial statements including balance sheets, income statements, cash flow statements, notes to financials, management discussion and analysis, risk factors, legal proceedings, and other comprehensive financial data. The length is substantial (15,000 characters) and the content includes unaudited condensed consolidated financial statements and management's discussion, which are typical of an interim or quarterly report. The form number 10-O is a variant of the quarterly report (similar to 10-Q). Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2007-05-08 English
Daily Share Buy-Back Notice 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a daily share buy-back notice submitted to the ASX (Australian Securities Exchange). It provides detailed information about the number of shares bought back, total consideration paid, highest and lowest prices paid, and compliance statements. The document is short (3007 characters) and focuses solely on share repurchase activity. It is not a full financial report, earnings release, or management discussion. It is a formal announcement of a transaction in the company's own shares. Therefore, the document fits the category 'Transaction in Own Shares' (POS).
2007-05-01 English
Daily Share Buy-Back Notice 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, highest and lowest prices paid, participation by directors, and compliance statements. The document is short (3007 characters) and focuses on reporting share repurchase activity rather than financial results or management commentary. It is not an announcement of a report but a direct notice of share buy-back activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS).
2007-05-01 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It details the issuance of ordinary shares under a stock option plan, including the number of shares issued, issue price, purpose, and dates related to the securities. The document references ASX rules and is structured as a formal announcement to the stock exchange regarding new securities issuance and quotation. There are no financial statements, management discussion, or audit information present. The content is consistent with a capital/financing update about new share issuance and listing. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed information about the securities issuance, not merely an announcement of a report, so it is not an RPA or RNS. Confidence is high due to clear alignment with the CAP category.
2007-04-26 English
Financial Results for Qtr & 9 Months ended 31/03/07 7 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of quarterly and nine-month financial results for ResMed Inc. for the period ended March 31, 2007. It includes comprehensive financial data such as revenue, income, expenses, and earnings per share, along with management commentary on performance and product recalls. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or press release. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2007-04-23 English
Issues a voluntary recall for certain S8 Flow Generators 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a press release announcing a voluntary recall of certain S8 Flow Generators by ResMed due to a potential short circuit issue. It provides details about the recall, affected serial numbers, safety instructions, and contact information for patients and regulatory authorities. There is no financial data, regulatory filing, or report attached or referenced. The content is a product safety recall announcement, which does not fit into financial report categories but is a regulatory announcement related to product safety and compliance. Given the nature of the document as a regulatory announcement about a product recall, the most appropriate classification is Regulatory Filings (RNS). The document length is under 5,000 characters and it is not a report publication announcement or certification, so RNS is the best fit.
2007-04-23 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.